BRIEF-Firebrick Pharma Announces License Agreement For Singapore, Malaysia, Brunei, Mauritius

Reuters

08/26

BRIEF-<a href="https://laohu8.com/S/FRE.AU">Firebrick Pharma</a> Announces License Agreement For Singapore, Malaysia, Brunei, Mauritius

Aug 26 (Reuters) - Firebrick Pharma Ltd FRE.AX:

LICENSE AGREEMENT FOR SINGAPORE, MALAYSIA, BRUNEI, MAURITIUS
NEW AGREEMENT EXPECTED TO SIGNIFICANTLY REDUCE FIREBRICK'S MARKETING EXPENSES IN FY26
INNORINI APPOINTED EXCLUSIVE LICENSEE FOR NASODINE PRODUCTS IN SINGAPORE, MALAYSIA, BRUNEI AND MAURITIUS

Further company coverage: FRE.AX

((Reuters.Briefs@thomsonreuters.com;))

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2562272296"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2562272296\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2562272296?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-26 09:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2562272296","market":"us","top_or_hot":-1,"title":"BRIEF-Firebrick Pharma Announces License Agreement For Singapore, Malaysia, Brunei, Mauritius","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/FRE.AU\">Firebrick Pharma</a> Announces License Agreement For Singapore, Malaysia, Brunei, Mauritius</title></head><body><p><span>Aug 26 (Reuters)</span><span> - </span>Firebrick Pharma Ltd <span>FRE.AX</span>:</p><ul><li><p>LICENSE AGREEMENT FOR SINGAPORE, MALAYSIA, BRUNEI, MAURITIUS</p></li><li><p>NEW AGREEMENT EXPECTED TO SIGNIFICANTLY REDUCE FIREBRICK'S MARKETING EXPENSES IN FY26</p></li><li><p>INNORINI APPOINTED EXCLUSIVE LICENSEE FOR NASODINE PRODUCTS IN SINGAPORE, MALAYSIA, BRUNEI AND MAURITIUS</p></li></ul><p>Further company coverage: <span>FRE.AX</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Firebrick Pharma Announces License Agreement For Singapore, Malaysia, Brunei, Mauritius</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Firebrick Pharma Announces License Agreement For Singapore, Malaysia, Brunei, Mauritius\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-08-26 09:16</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/FRE.AU\">Firebrick Pharma</a> Announces License Agreement For Singapore, Malaysia, Brunei, Mauritius</title></head><body><p><span>Aug 26 (Reuters)</span><span> - </span>Firebrick Pharma Ltd <span>FRE.AX</span>:</p><ul><li><p>LICENSE AGREEMENT FOR SINGAPORE, MALAYSIA, BRUNEI, MAURITIUS</p></li><li><p>NEW AGREEMENT EXPECTED TO SIGNIFICANTLY REDUCE FIREBRICK'S MARKETING EXPENSES IN FY26</p></li><li><p>INNORINI APPOINTED EXCLUSIVE LICENSEE FOR NASODINE PRODUCTS IN SINGAPORE, MALAYSIA, BRUNEI AND MAURITIUS</p></li></ul><p>Further company coverage: <span>FRE.AX</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7096","symbol_name":"製藥","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250826:nFWN3UH0N6:1","article_id":"2562272296","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2562272296","pubTimestamp":1756170979,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Firebrick Pharma Announces License Agreement For Singapore, Malaysia, Brunei, MauritiusAug 26  - Firebrick Pharma Ltd FRE.AX:LICENSE AGREEMENT FOR SINGAPORE, MALAYSIA, BRUNEI, MAURITIUSNEW AGREEMENT EXPECTED TO SIGNIFICANTLY REDUCE FIREBRICK'S MARKETING EXPENSES IN FY26INNORINI APPOINTED EXCLUSIVE LICENSEE FOR NASODINE PRODUCTS IN SINGAPORE, MALAYSIA, BRUNEI AND MAURITIUSFurther company coverage: FRE.AX ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7096":"制药","FRE.AU":"FIREBRICK PHARMA LTD"},"translate_title":"简介-Firebrick Pharma宣布新加坡、马来西亚、文莱、毛里求斯的许可协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FRE.AU":0.9},"content_text":"BRIEF-Firebrick Pharma Announces License Agreement For Singapore, Malaysia, Brunei, MauritiusAug 26 (Reuters) - Firebrick Pharma Ltd FRE.AX:LICENSE AGREEMENT FOR SINGAPORE, MALAYSIA, BRUNEI, MAURITIUSNEW AGREEMENT EXPECTED TO SIGNIFICANTLY REDUCE FIREBRICK'S MARKETING EXPENSES IN FY26INNORINI APPOINTED EXCLUSIVE LICENSEE FOR NASODINE PRODUCTS IN SINGAPORE, MALAYSIA, BRUNEI AND MAURITIUSFurther company coverage: FRE.AX ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}